The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
Public ClinicalTrials.gov record NCT06796504. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT06796504
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- SetPoint Medical Corporation
- Industry
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- Device: Active stimulation Device
- Device: Non-active stimulation Device
- Disease-Modifying Therapies (DMTs) Drug
- Procedure/Surgery: Implant Procedure Procedure
Device · Drug · Procedure
Eligibility (public fields only)
- Age range
- 22 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 16, 2026
- Primary completion
- Dec 30, 2027
- Completion
- Sep 29, 2030
- Last update posted
- May 18, 2026
2026 – 2030
United States locations
- U.S. sites
- 6
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Shepherd Center | Atlanta | Georgia | 30309 | Recruiting |
| Johns Hopkins School of Medicine | Baltimore | Maryland | 21287 | Recruiting |
| Minnesota Center for Multiple Sclerosis | Plymouth | Minnesota | 55446 | Recruiting |
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | Recruiting |
| UW Medicine Multiple Sclerosis Center-Northwest | Seattle | Washington | 98133 | Recruiting |
| West Virginia University | Morgantown | West Virginia | 26506 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06796504, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06796504 live on ClinicalTrials.gov.